FDC Limited

FDC

Market snapshot · 2026-08-11 06:37 UTC

₹356.50

₹-3.85 (-1.07%)

MARKET CAP

₹5.80K Cr

STOCK P/E

20.6x

52W HIGH

₹527.80

52W LOW

₹312.95

BOOK VALUE

₹152.62

EPS

₹17.31

ROE

—

SECTOR

Healthcare

DEBT/EQUITY

0.62

VOLUME

1.17L

P/B RATIO

2.34x

PEG RATIO

2.22

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic

Dividend

AI Summary

✦ Clartha

Price Forecast

Current

₹356.50

High Target

—

Median Target

—

Low Target

—

Price history (1Y)

Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange (₹)Probability

3M₹270.59 - ₹393.0980%

6M₹229.12 - ₹388.5380%

12M₹171.88 - ₹362.7480%

Realized vol: +29.1% · Drift: -31.4%

Revenue Forecast

₹ Cr

Jun '26Current₹655.0

Sep 2026 ETrend estimate range

High₹530.3Base₹491.0Low₹451.7

PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share

Jun '26Current₹8.11

Sep 2026 ETrend estimate range

High₹2.74Base₹2.44Low₹2.15

PastCurrentTrend estimate: Low / Base / High

Analyst price target unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.

Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook

Mixed

49%

Analyst Consensus

Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Moderate

Fundamentals institutional score is 59 using growth durability 59.1.

Valuation

Attractive relative to peers

Valuation institutional score is 74 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Weak Structure

Technicals institutional score is 6 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Neutral backdrop

Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.

Signal Summary

Market intelligence remains Mixed. valuation provide support, while technical structure and market sentiment remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals ModerateValuation Attractive relative to peersTechnical Structure Weak StructureMarket Sentiment Neutral backdrop

Key Data Points

Mean Target PriceUnavailable

Mean UpsideNot available

Technical Score7%

Fundamental Score59%

Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 15.8% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.4). Confidence: 88%.

Live forward EPS implies next-12-month EPS of ₹23.30. Applying the stock's normalized valuation corridor produces a fair range of ₹522.15 to ₹631.66, with base value near ₹569.68 (+59.8% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Below normalized range

Forward EPS

₹23.30

Forward P/E

15.3x

Base Fair Value

₹569.68

Fair Range

₹522.15 - ₹631.66

Upside To Base

+59.8%

Estimate Source

Live forward EPS

Growth Estimate

+9.3%

P/E

5Y Average

21.28

Current

20.60

Overvalued

27.11

Undervalued

22.41

EV/EBITDA

5Y Average

15.72

Current

15.21

Overvalued

18.28

Undervalued

12.26

P/S

5Y Average

2.74

Current

2.65

Overvalued

3.15

Undervalued

2.33

Peers & Comparison

Sector: Healthcare

No peer data available for this company.

WHY THESE PEERS

Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹655 CrJun 2026

Latest net profit

₹132 CrJun 2026

Latest EPS

₹8.11Jun 2026

Net margin

22.0%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %

Revenue
Net income
Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share

Revenue
EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore

Annual view

Debt
Free cash flow
Cash & equivalents

Results

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales +	530	480	452	454	624	505	459	482	642	462	458	564	655
Expenses +	410	401	370	396	482	433	413	429	501	427	408	453	512
Operating Profit	120	79	82	58	142	72	46	53	141	35	50	112	143
OPM %	23%	16%	18%	13%	23%	14%	10%	11%	22%	8%	11%	20%	22%
Other Income +	30	27	25	21	28	35	19	31	36	21	1	47	47
Interest	1	1	1	1	1	1	1	1	1	1	1	2	1
Depreciation	10	10	10	10	11	14	13	16	15	15	15	14	15
Profit before tax	139	95	96	67	158	92	50	68	161	39	35	143	174
Tax %	22%	24%	19%	28%	27%	20%	28%	29%	24%	25%	22%	25%	24%
Net Profit +	109	72	78	48	115	74	36	48	122	29	27	107	132
EPS in Rs	6.54	4.42	4.81	2.96	7.06	4.54	2.24	2.96	7.51	1.81	1.67	6.58	8.11
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

Holder	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters +	69.66%	69.66%	69.66%	69.65%	69.65%
FIIs +	2.41%	2.43%	2.32%	2.40%	1.40%
DIIs +	7.17%	6.81%	6.27%	6.29%	6.31%
Public +	20.76%	21.10%	21.76%	21.65%	22.63%
Others	—	—	—	0.01%	0.01%

Jun 2026

Promoters +

FIIs +

DIIs +

Public +

Others

Events Timeline

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aug 05, 2026PDFCompany Reports Open

Financial Results For The Quarter Ended June 30, 2026

Aug 05, 2026PDFCompany Reports Open

Board Meeting Outcome for Board Meeting Outcome For Outcome For The Board Meeting Held On August 05, 2026.

Aug 05, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 27, 2026PDFCompany Reports Open

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 05, 2026.

Jul 23, 2026PDFCompany Reports Open